MiNK Therapeutics, Inc.
INKT • NASDAQ • Stock Fundamentals
MiNK Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jennifer S. Buell, with a market cap of $52.0M.
Market Cap$52.0M
Employees37.0
CEOJennifer S. Buell
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 13 days agoQ1 2026
View reportNext EarningsAug 13, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
MiNK Therapeutics, Inc. FAQ
Common questions about MiNK Therapeutics, Inc.
MiNK Therapeutics, Inc. (INKT) has a market capitalization of $52.0M and trades on NASDAQ.
MiNK Therapeutics, Inc. has approximately 37 employees.